Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

2.1K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
2.1K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

383
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
383
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

503
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
503
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

525
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
525
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

339
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
339
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

639
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
639

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peritoneal malignancy in the global COVID-19 pandemic: experience of recovery and restoration in a high-volume centre through NHS and independent sector collaboration.

Annals of the Royal College of Surgeons of England·2023
Same author

Suboptimal exposure to fluconazole in critically ill patients: Pharmacokinetic analysis and determinants.

Infectious diseases now·2022
Same author

Sickle cell bone disease and response to intravenous bisphosphonates in children.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2022
Same author

Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double-blind multicentre study.

The British journal of dermatology·2021
Same author

No observed reduction of non-attendance rate in telehealth models of care.

Australian health review : a publication of the Australian Hospital Association·2020
Same author

Frontal fibrosing alopecia: a descriptive cross-sectional study of 711 cases in female patients from the UK.

The British journal of dermatology·2020

Related Experiment Video

Updated: Apr 20, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.4K

[Impact of a program designed to improve continuous renal replacement therapy stability].

M Page1, T Rimmelé1, J Prothet1

  • 1Service d'anesthésie-réanimation, pavillon P réanimation, hôpital Édouard-Herriot, 5, place d'Arsonval, 69437 Lyon cedex 03, France.

Annales Francaises D'Anesthesie Et De Reanimation
|December 3, 2014
PubMed
Summary

Implementing a new program significantly reduced unexpected circuit clotting during continuous renal replacement therapy (CRRT), improving filter lifespan and therapy stability.

Keywords:
Anticoagulation régionale au citrateCircuit clottingHemodialysisHemofiltrationHémodialyseHémofiltrationRegional citrate anticoagulationThrombose de filtreTinuous renal replacement therapyÉpuration extrarénale

More Related Videos

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

3.3K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

897

Related Experiment Videos

Last Updated: Apr 20, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

5.4K
Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
03:13

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research

Published on: November 3, 2023

3.3K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

897

Area of Science:

  • Nephrology and Critical Care Medicine
  • Renal Replacement Therapies
  • Biomedical Engineering

Context:

  • Continuous renal replacement therapy (CRRT) is vital for critically ill patients.
  • Circuit clotting is a major complication, increasing workload, costs, and blood loss.
  • Improving CRRT stability is crucial for patient outcomes and resource management.

Purpose:

  • To evaluate the effectiveness of a multifaceted program aimed at enhancing CRRT stability.
  • To assess the program's impact on reducing unexpected circuit clotting events.
  • To analyze changes in CRRT filter lifespan post-intervention.

Summary:

  • A retrospective observational study analyzed 401 CRRT sessions before (2009-2010) and after (2011-2012) program implementation.
  • The program included regional citrate anticoagulation, super high-flux membranes, and specialized nurse training.
  • Unexpected CRRT session ends decreased from 40% to 17% (P<0.0001), and median filter life extended from 33 to 55 hours (P<0.0001).

Impact:

  • The implemented program successfully reduced unexpected circuit clotting in CRRT.
  • Enhanced CRRT stability leads to fewer therapy interruptions and improved filter utilization.
  • This intervention offers a potential strategy to optimize CRRT management in intensive care settings.